A Multicenter, Randomized, Double-Blind, Placebo-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of AVTR101 in Sarcopenia Patients
Latest Information Update: 30 Jan 2025
Price :
$35 *
At a glance
- Drugs AVTR 101 (Primary)
- Indications Sarcopenia
- Focus Therapeutic Use
- Sponsors Aventi Biotechnology
- 30 Jan 2025 New trial record